Alembic Pharmaceuticals Ltd
Ramu Galipalli has a diverse work experience in the pharmaceutical industry. Ramu began their career as a Research Associate at Nagarjuna Fertilizers and Chemicals Limited in 2013, where they worked until 2017. Ramu then joined ISSAR PHARMACEUTICALS as a Scientist in 2017, before moving on to Alembic Pharmaceuticals Limited in 2018. At Alembic, Ramu took on the role of Senior Scientist from 2018 to 2020, and later became a Team Lead. Ramu has demonstrated expertise in various aspects of the pharmaceutical field throughout their career.
Ramu Galipalli received their Bachelor of Science degree in Chemistry from Kakatiya University in 2009. Prior to that, they completed their 10+2 education in the field of MPC from the Board of Intermediate in 2006. Ramu went on to pursue a Master of Science degree in Chemistry from the Indian Institute of Technology, Delhi, completing it in 2012.
This person is not in the org chart
This person is not in any offices
Alembic Pharmaceuticals Ltd
9 followers
Alembic Pharmaceuticals Limited is a pharmaceutical company. The Company is engaged developing formulations and active pharmaceutical ingredients (API). The Company focuses on anti-infective, analgesic and, cough and cold therapies. It also focuses on therapies, such as cardiology, diabetes, gynecology, gastrointestinal, orthopedic, dermatology and ophthalmology. Its APIs include independent manufacturing blocks for Macrolides, non-steroidal anti-inflammatory drugs (NSAIDs) and other drugs. The Company offers international and domestic formulations. Under domestic formulation, it offers Branded Formulations and Generic formulations. Its domestic formulation include Roxid, Zofix, Althrocin, Tellzy AH, Revas H, Lactonic, Folinal, Gestofit, Glisen 1/2, Glimser 1/2, Veldrop, Azithral, Brinzemic and Neolap. Its generic formulations include Cetral, Ephedrex CD, Sicor, Worid, Alcephin, Alcizon, Baciclox, Comeba, Furobid, O Win Suspension, O win T, Silomag Gel, Pentab, Aginal AT and Pyremol.